Edition:
India

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

44.35EUR
5:43pm IST
Change (% chg)

€0.00 (+0.00%)
Prev Close
€44.35
Open
€44.50
Day's High
€44.63
Day's Low
€43.64
Volume
654,422
Avg. Vol
1,658,372
52-wk High
€69.90
52-wk Low
€38.28

Select another date:

Sun, Sep 15 2019

Fresenius drops possible sale of blood transfusion unit - spokesman

FRANKFURT, Sept 15 German health care group Fresenius has abandoned plans to sell its blood transfusion business, a spokesman said on Sunday, confirming a German media report.

Fresenius' Helios division acquires two hospitals in Colombia

BERLIN German healthcare group Fresenius said on Tuesday its hospitals division Helios had acquired two hospitals in Colombia for 50 million euros ($55.72 million) as the group strengthens its presence outside of Europe.

Fresenius' Helios division acquires two hospitals in Colombia

BERLIN, Sept 3 German healthcare group Fresenius said on Tuesday its hospitals division Helios had acquired two hospitals in Colombia for 50 million euros ($55.72 million) as the group strengthens its presence outside of Europe.

UPDATE 4-Fresenius slides as weakness in dialysis unit offsets improved outlook

* Fresenius expects FY 4%-7% revenue growth at constant currency

Fresenius raises full-year outlook after Q2 meets expectations

July 30 German healthcare group Fresenius raised full-year revenue targets on Tuesday as its adjusted second-quarter sales came in a touch above analysts' expectations.

Fresenius says tighter EU rules could trigger antibiotic shortage

FRANKFURT German drugmaker Fresenius warned that stricter production norms being considered by Europe's drug regulator could compound shortages of a life-saving antibiotic that is used by about 25 million patients globally each year.

Fresenius says tighter EU rules could trigger antibiotic shortage

FRANKFURT German drugmaker Fresenius warned that stricter production norms being considered by Europe's drug regulator could compound shortages of a life-saving antibiotic that is used by about 25 million patients globally each year.

Fresenius says tighter EU rules could trigger antibiotic shortage

* Regulator EMA working on revision of manufacturing guidelines

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN, May 17 German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

Select another date: